Epithelial Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials

AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer
Conditions:   Carcinoma, Ovarian Epithelial;   Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Peritoneal Neoplasms;   Neoplasms, Glandular and Epithelial;   Ovarian Diseases;   Genital Neoplasm, Female;   Abdominal Neoplasm;   Recurrence Intervention:   Biological: AB-1015 Sponsor:   Arsenal Biosciences, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2022 Category: Research Source Type: clinical trials

AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer
Conditions:   Carcinoma, Ovarian Epithelial;   Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Peritoneal Neoplasms;   Neoplasms, Glandular and Epithelial;   Ovarian Diseases;   Genital Neoplasm, Female;   Abdominal Neoplasm;   Recurrence Intervention:   Biological: AB-1015 Sponsor:   Arsenal Biosciences, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2022 Category: Research Source Type: clinical trials

AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer
Conditions:   Carcinoma, Ovarian Epithelial;   Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Peritoneal Neoplasms;   Neoplasms, Glandular and Epithelial;   Ovarian Diseases;   Genital Neoplasm, Female;   Abdominal Neoplasm;   Recurrence Intervention:   Biological: AB-1015 Sponsor:   Arsenal Biosciences, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2022 Category: Research Source Type: clinical trials